IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

Jani Huuhtanen; Mette Ilander; Bhagwan Yadav; Olli M. J. Dufva; Hanna Lähteenmäki; Tiina Kasanen; Jay Klievink; Ulla Olsson-Strömberg; Jesper Stentoft; Johan Richter; Perttu Koskenvesa; Martin Hoglund; Stina Söderlund; Arta Dreimane; Kimmo Porkka; Tobias Gedde-Dahl; Bjorn T. Gjertsen; Leif Stenke; Kristina Myhr-Eriksson; Berit Markevarn; Anna Lubking; Andreja Dimitrijevic; Lene Udby; Ole Weis Bjerrum; Henrik Hjorth-Hansen; Satu Mustjoki

doi:10.1172/JCI152585

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

Jani Huuhtanen, Mette Ilander, Bhagwan Yadav, Olli M. J. Dufva, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Ulla Olsson-Strömberg, Jesper Stentoft, Johan Richter, Perttu Koskenvesa, Martin Hoglund, Stina Söderlund, Arta Dreimane, Kimmo Porkka, Tobias Gedde-Dahl, Bjorn T. Gjertsen, Leif Stenke, Kristina Myhr-Eriksson, Berit MarkevarnAnna Lubking, Andreja Dimitrijevic, Lene Udby, Ole Weis Bjerrum, Henrik Hjorth-Hansen, Satu Mustjoki

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Artikelnummer	152585
Tidskrift	Journal of Clinical Investigation
Volym	132
Nummer	17
Antal sidor	17
ISSN	0021-9738
DOI	https://doi.org/10.1172/JCI152585
Status	Publicerad - 1 sep. 2022
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin
3122 Cancersjukdomar

Åtkomst av dokument

10.1172/JCI152585

JCI152585.v1Slutlig publicerad version, 3,07 MBLicens: CC BY

Citera det här

Huuhtanen, J., Ilander, M., Yadav, B., Dufva, O. M. J., Lähteenmäki, H., Kasanen, T., Klievink, J., Olsson-Strömberg, U., Stentoft, J., Richter, J., Koskenvesa, P., Hoglund, M., Söderlund, S., Dreimane, A., Porkka, K., Gedde-Dahl, T., Gjertsen, B. T., Stenke, L., Myhr-Eriksson, K., ... Mustjoki, S. (2022). IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia. Journal of Clinical Investigation, 132(17), Artikel 152585. https://doi.org/10.1172/JCI152585

@article{038d91e696b246be82dfa21105711bb7,

title = "IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia",

keywords = "MATURE NK-CELLS, MOLECULAR RESPONSE, IMATINIB DISCONTINUATION, STEM-CELLS, T-CELLS, THERAPY, NILOTINIB, EFFICACY, MAINTENANCE, COMBINATION, 3121 General medicine, internal medicine and other clinical medicine, 3122 Cancers",

author = "Jani Huuhtanen and Mette Ilander and Bhagwan Yadav and Dufva, {Olli M. J.} and Hanna L{\"a}hteenm{\"a}ki and Tiina Kasanen and Jay Klievink and Ulla Olsson-Str{\"o}mberg and Jesper Stentoft and Johan Richter and Perttu Koskenvesa and Martin Hoglund and Stina S{\"o}derlund and Arta Dreimane and Kimmo Porkka and Tobias Gedde-Dahl and Gjertsen, {Bjorn T.} and Leif Stenke and Kristina Myhr-Eriksson and Berit Markevarn and Anna Lubking and Andreja Dimitrijevic and Lene Udby and Bjerrum, {Ole Weis} and Henrik Hjorth-Hansen and Satu Mustjoki",

year = "2022",

month = sep,

day = "1",

doi = "10.1172/JCI152585",

language = "English",

volume = "132",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "AMERICAN SOCIETY FOR CLINICAL INVESTIGATION",

number = "17",

}

Huuhtanen, J , Ilander, M , Yadav, B, Dufva, OMJ, Lähteenmäki, H, Kasanen, T, Klievink, J, Olsson-Strömberg, U, Stentoft, J, Richter, J, Koskenvesa, P, Hoglund, M, Söderlund, S, Dreimane, A, Porkka, K, Gedde-Dahl, T, Gjertsen, BT, Stenke, L, Myhr-Eriksson, K, Markevarn, B, Lubking, A, Dimitrijevic, A, Udby, L, Bjerrum, OW, Hjorth-Hansen, H & Mustjoki, S 2022, 'IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia', Journal of Clinical Investigation, vol. 132, nr. 17, 152585. https://doi.org/10.1172/JCI152585

TY - JOUR

T1 - IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

AU - Huuhtanen, Jani

AU - Ilander, Mette

AU - Yadav, Bhagwan

AU - Dufva, Olli M. J.

AU - Lähteenmäki, Hanna

AU - Kasanen, Tiina

AU - Klievink, Jay

AU - Olsson-Strömberg, Ulla

AU - Stentoft, Jesper

AU - Richter, Johan

AU - Koskenvesa, Perttu

AU - Hoglund, Martin

AU - Söderlund, Stina

AU - Dreimane, Arta

AU - Porkka, Kimmo

AU - Gedde-Dahl, Tobias

AU - Gjertsen, Bjorn T.

AU - Stenke, Leif

AU - Myhr-Eriksson, Kristina

AU - Markevarn, Berit

AU - Lubking, Anna

AU - Dimitrijevic, Andreja

AU - Udby, Lene

AU - Bjerrum, Ole Weis

AU - Hjorth-Hansen, Henrik

AU - Mustjoki, Satu

PY - 2022/9/1

Y1 - 2022/9/1

KW - MATURE NK-CELLS

KW - MOLECULAR RESPONSE

KW - IMATINIB DISCONTINUATION

KW - STEM-CELLS

KW - T-CELLS

KW - THERAPY

KW - NILOTINIB

KW - EFFICACY

KW - MAINTENANCE

KW - COMBINATION

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - 3122 Cancers

U2 - 10.1172/JCI152585

DO - 10.1172/JCI152585

M3 - Article

SN - 0021-9738

VL - 132

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 17

M1 - 152585

ER -